Intracameral Injection

This is a type of injection where medicine is put directly into the front part of the eye, called the anterior chamber. It's often used to treat certain eye conditions.

Procedure

What people who've had Intracameral Injection report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Intracameral Injection

Who It's For

An intracameral injection places medicine directly into the anterior chamber, the small fluid-filled space at the front of the eye between the clear cornea and the colored iris. Putting a drug there delivers it right where it is needed, in a dose that eye drops cannot reliably reach and without exposing the rest of the body to much medicine. Most people meet this procedure as one step inside cataract surgery. At the end of the operation, many surgeons inject an antibiotic such as cefuroxime or moxifloxacin into the front chamber to lower the chance of endophthalmitis, a rare but serious infection inside the eye that can permanently damage vision. Large studies show this reduces infections after cataract surgery. In the United States these antibiotic injections are usually prepared by a compounding pharmacy or adapted from preservative-free eye drops, so practice varies between surgeons. Surgeons may also inject a numbing medicine such as lidocaine or a pupil-widening medicine during the same operation. The other main use is glaucoma. Two FDA-approved implants are injected into the front chamber to release a glaucoma medicine slowly and lower eye pressure in open-angle glaucoma or ocular hypertension (high eye pressure without nerve damage yet): Durysta, a dissolving implant containing bimatoprost, and iDose TR, a small implant containing travoprost that is anchored in the eye's drainage area. Both drugs belong to the prostaglandin family used in common glaucoma drops. An implant can reduce or delay the need for daily drops, which helps people who struggle to use drops consistently, but it does not replace regular glaucoma monitoring.

Before the Procedure

When the injection is part of cataract surgery, preparation is the cataract surgery preparation: an eye exam and measurements, a review of your medicines and instructions about eating, drinking and eye drops on the day. Tell the surgeon about any allergy to antibiotics, especially cephalosporins such as cefuroxime or fluoroquinolones such as moxifloxacin, because that affects which antibiotic is chosen. Before a glaucoma implant, the eye doctor checks that the eye is a good fit. The implants are not used when there is an active infection in or around the eye, a disease of the cornea's inner cell layer such as Fuchs dystrophy, or a previous corneal transplant. Durysta is also not used when the capsule that holds the lens is missing or torn, because the implant could drift to the back of the eye. Narrow drainage angles call for extra caution, and the doctor may measure the corneal cell count beforehand. If you will receive sedation or are having surgery, arrange for someone to drive you home.

During the Procedure

During cataract surgery, an intracameral injection usually goes unnoticed as a separate step. The eye is already numb and open through tiny incisions, and the surgeon injects a small measured amount of medicine through one of them, often at the very end of the operation. Most people are awake with numbing drops and sometimes light sedation, and the whole surgery commonly takes under an hour. Durysta is placed with a preloaded applicator, either at a slit lamp (the microscope used in eye exams) while you sit, or under an operating microscope while you lie back. After numbing drops and an antiseptic cleaning, the doctor passes a fine needle through the edge of the cornea, releases the tiny implant into the front chamber and withdraws the needle. The puncture usually seals itself. The step itself takes a few minutes, and you may feel pressure rather than pain. iDose TR is placed in an operating room through a small incision at the edge of the cornea, with the implant anchored in the drainage tissue of the eye. The eye is numbed with drops or other anesthesia chosen by the surgical team.

Recovery & Aftercare

After cataract surgery, the eye often feels scratchy, a little sore or sensitive to light for a day or two, and vision may be blurry at first. You will usually use prescribed eye drops for several weeks and may wear a shield at night. After a glaucoma implant, mild redness, a gritty feeling and light sensitivity are common for a short time, and most people return to normal activities quickly. Follow-up visits matter. After cataract surgery they check healing and pressure. After a glaucoma implant, the doctor checks eye pressure, the position of the implant and the cornea over time, because the pressure-lowering effect eventually wears off and further treatment may be needed. Durysta is designed to release medicine over roughly four to six months, although the effect lasts longer in some people. If you have iDose TR, keep the implant ID card and tell anyone ordering an MRI scan that it is in your eye. Call your eye doctor right away if the eye becomes more painful, more red or more sensitive to light instead of gradually settling, or if vision gets worse or you notice new floaters or flashes. These can be early signs of infection or severe inflammation, which are treated most successfully when caught early.

Risks & Complications

The most serious risk of anything placed inside the eye is endophthalmitis, an infection that can threaten sight. It is rare, and an antibiotic given in the front chamber during cataract surgery is itself one of the main ways surgeons prevent it. A related problem, toxic anterior segment syndrome, is a sterile inflammation caused by something introduced into the eye rather than by germs. It typically appears within one to two days with blurred vision and discomfort and needs prompt treatment to protect the cornea. The choice of antibiotic matters. Vancomycin injected inside the eye has been strongly linked to hemorrhagic occlusive retinal vasculitis, a rare reaction in the blood vessels of the retina that can appear about a week or more after surgery and often causes severe vision loss. Expert task forces have urged surgeons to weigh this risk against the benefit of infection prevention, and some now choose a different antibiotic. Glaucoma implants carry their own trade-offs. They can contribute to loss of cells on the inner surface of the cornea, which keep it clear, so the Durysta label limits treatment to one implant per eye. Other possible effects include eye redness (the most common, in about a quarter of people in Durysta's trials), inflammation, swelling at the center of the retina, a rise in eye pressure, movement of the implant, and permanent darkening of the iris to a browner color.

Questions to Ask Your Doctor

  1. 1.Will an antibiotic be injected into my eye during cataract surgery, and which one do you use?
  2. 2.Am I a good candidate for a glaucoma implant, or should I stay on eye drops or consider a laser or surgical option?
  3. 3.How long is an implant likely to control my eye pressure, and what happens when it wears off?
  4. 4.Will you check my cornea before and after the implant, and how often will I need follow-up visits?
  5. 5.Which symptoms after the procedure should make me call you the same day?

Last reviewed • Oct 2026

Educational content, not medical advice.